Department of Orthopaedic Surgery, College of Medicine, University of Hallym, Chuncheon, Korea.
Knee Surg Sports Traumatol Arthrosc. 2011 Oct;19(10):1755-9. doi: 10.1007/s00167-010-1362-3. Epub 2011 Jan 13.
The purpose of this study was to describe a modified trans-tendon method of repairing partial articular surface lesions, which restored the footprint of the rotator cuff anatomically.
The 24 consecutive patients with modified trans-tendon method which allowed a wider pressurized contact area by use of additional knotless anchor were included in this study. All patients were evaluated with ASES score and visual analog scale (VAS) preoperatively, postoperative 3 and 12 months. The strength was measured using Isobex digital strength analyzer preoperatively and postoperative 12 months.
The ASES scores significantly improved from preoperative 38 ± 13 to 63 ± 5 at 3 months, and 89 ± 5 at 12 months postoperatively. The VAS scores also significantly improved from preoperative 6.6 ± 1.1 to 2 ± 0.7 at 3 months, 0.6 ± 0.7 at 12 months. The strengths significantly increased postoperatively, and there were no significant differences between affected and unaffected shoulders at 12 months postoperatively (P > 0.05). The 22 of 24 patients were either satisfied or very satisfied with postoperative result at 12 months postoperatively.
This arthroscopic-modified trans-tendon suture bridge technique for partial-thickness articular side tears of the rotator cuff has shown excellent functional results and very high satisfaction rate of patient during the 12-month follow-up period.
Evidence therapeutic study, Level IV.
本研究旨在描述一种改良经腱方法修复部分关节面损伤，该方法可使冈上肌腱的解剖足印得以重建。
本研究纳入了 24 例连续接受改良经腱方法治疗的患者，该方法通过使用额外的无结锚钉来实现更广泛的加压接触面积。所有患者均在术前、术后 3 个月和 12 个月时进行 ASES 评分和视觉模拟评分（VAS）评估。术前和术后 12 个月使用 Isobex 数字力量分析仪测量力量。
ASES 评分从术前的 38±13 显著提高到术后 3 个月的 63±5，以及术后 12 个月的 89±5。VAS 评分也从术前的 6.6±1.1 显著改善到术后 3 个月的 2±0.7，以及术后 12 个月的 0.6±0.7。术后力量显著增加，且术后 12 个月患侧和健侧之间无显著差异（P＞0.05）。24 例患者中有 22 例在术后 12 个月时对术后结果非常满意或满意。
在 12 个月的随访期间，关节镜下改良经腱缝合桥技术治疗冈上肌腱部分厚度关节侧撕裂显示出优异的功能结果和非常高的患者满意度。
治疗学研究，IV 级。
